四月 2026
revlimid.com
显示 Similarweb 估计数据。
关联 GA4,公开验证您的网站指标
与您的成功同步
绑定 Google Analytics,验证您网站的流量及用户参与度指标
跳出率
42.91%
每次访问页数
1.69
平均访问时长
00:00:26
- 公司
- - -
- 行业
- - -
revlimid.com的 10 大竞争对手
在 四月 2026 与 revlimid.com 相似的前 10 名网站,按关键字流量、受众定位和市场重叠方面与 revlimid.com 的关联性排名
important safety information warning: embryo-fetal toxicity and venous thromboembolism embryo-fetal toxicity if thalidomide is taken during pregnancy, it can cause severe birth defects or embryo-fetal death. thalidomide should never be used by females who are pregnant or who could become pregnant while taking the drug. even a single dose [1 capsule (regardless of strength)] taken by a pregnant woman during her pregnancy can cause severe birth defects because of this toxicity and in an effort to make the chance of embryo-fetal exposure to thalomid® (thalidomide) as negligible as possible, thalomid® (thalidomide) is approved for marketing only through a special restricted distribution program: thalomid rems® program, approved by the food and drug administration you can get the information about thalomid and the thalomid rems® program on the internet at www.celgeneriskmanagement.com or by calling the manufacturer's toll-free number 1-888-423-5436 venous thromboembolism the use of thalomid (thalidomide) in multiple myeloma results in an increased risk of venous thromboembolism, such as deep venous thrombosis and pulmonary embolism. this risk increases significantly when thalidomide is used in combination with standard chemotherapeutic agents including dexamethasone. in one controlled trial, the rate of venous thromboembolism was 22.5% in patients receiving thalidomide in combination with dexamethasone compared to 4.9% in patients receiving dexamethasone alone (p = 0.002). patients and physicians are advised to be observant for the signs and symptoms of thromboembolism. instruct patients to seek medical care if they develop symptoms such as shortness of breath, chest pain, or arm or leg swelling. consider thromboprophylaxis based on an assessment of individual patients’ underlying risk factors contraindications pregnancy: see boxed warnings. thalomid can cause fetal harm when administered to a pregnant female. thalomid is contraindicated in females who are pregnant. thal
- 公司
- - -
- 行业
- - -
全球排名
- -
国家/地区排名
- -
品类排名
- -
跳出率
- -
每次访问页数
- -
平均访问时长
- -
相似度评分
100%The FDA is responsible for protecting and promoting the public health
跳出率
57.63%
每次访问页数
2.77
平均访问时长
00:02:28
相似度评分
91%Explore POMALYST® (pomalidomide) treatment, a prescription medication used to treat adults. See Safety Info & Boxed WARNINGS on birth defects and blood clots.
- 公司
- - -
- 行业
- - -
跳出率
38.54%
每次访问页数
1.41
平均访问时长
00:00:04
Transforming cancer care through innovative medicines, pioneering research & patient-first approach. Explore our pipeline, therapies & commitment.
- 公司
- - -
- 行业
- - -
全球排名
- -
国家/地区排名
- -
品类排名
- -
跳出率
- -
每次访问页数
- -
平均访问时长
- -
相似度评分
84%Patch innovation in CINV Prevention. Sancuso® is the only FDA-approved transdermal patch for chemotherapy-induced nausea and vomiting
- 公司
- - -
- 行业
- - -
跳出率
35.46%
每次访问页数
1.28
平均访问时长
00:00:05
相似度评分
83%breakthrough science. one moment, one day, one person at a time.
- 公司
- - -
- 行业
- - -
全球排名
- -
国家/地区排名
- -
品类排名
- -
跳出率
- -
每次访问页数
- -
平均访问时长
- -
相似度评分
81%Learn more about ADCETRIS. See Important Safety Information, including BOXED WARNING, and Important Facts.
- 公司
- - -
- 行业
- - -
跳出率
63%
每次访问页数
1.70
平均访问时长
00:02:17
learn about canasa (mesalamine) 1000 mg rectal suppository, a prescription medicine used to treat adults with mildly to moderately active ulcerative proctitis. view safety and full prescribing information, read disease information, and access patient resources.
- 公司
- - -
- 行业
- - -
全球排名
- -
国家/地区排名
- -
品类排名
- -
跳出率
- -
每次访问页数
- -
平均访问时长
- -
相似度评分
80%for more than a century, merck has been inventing medicines and vaccines for many of the world's most challenging diseases. we have always been and always will be inventing, and we do it for the single greatest purpose: life.
- 公司
- - -
- 行业
- - -
全球排名
- -
国家/地区排名
- -
品类排名
- -
跳出率
- -
每次访问页数
- -
平均访问时长
- -
相似度评分
80%phn treatment – gralise (gabapentin) tablets
- 公司
- - -
- 行业
- - -
跳出率
40.34%
每次访问页数
1.62
平均访问时长
00:00:28
相似度评分
80%revlimid.com在 四月 2026 的前五名竞争对手是:thalomid.com、fda.gov、pomalyst.com、velcade.com等。
根据 Similarweb 的月访问量数据,revlimid.com 在 四月 2026 的头号竞争对手是 thalomid.com。与 revlimid.com 相似度排名第二的网站是 fda.gov,排名第三的是 pomalyst.com。
在 四月 2026,velcade.com 被评为与 revlimid.com 相似度第四高的网站,sancuso.com 位居第五。
进入前十名榜单的其他五家竞争对手分别是 tarceva.com、adcetris.com、canasa.com、invanz.com 和 gralise.com。
